Fosfluconazole for antifungal prophylaxis in very low birth weight infants

Daijiro Takahashi1, Tomohiko Nakamura, Reiko Shigematsu

  • 1Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan.

Insights

Fosfluconazole prophylaxis effectively prevented invasive fungal infections in very low birth weight infants. This antifungal treatment showed good tolerability, with no significant impact on liver or renal function.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Very low birth weight (VLBW) infants are highly susceptible to invasive fungal infections (IFIs).
  • Central vascular catheters increase the risk of IFIs in this vulnerable population.
  • Antifungal prophylaxis is crucial for IFI prevention in VLBW infants.

Purpose of the Study:

  • To evaluate the safety and efficacy of fosfluconazole prophylaxis for preventing IFIs.
  • To assess the tolerability of fosfluconazole in VLBW infants with central vascular access.

Main Methods:

  • Retrospective case series study.
  • Inclusion of 23 VLBW infants receiving intravenous fosfluconazole (6 mg/kg daily) during central venous catheter placement.
  • Monitoring for fungal infections, beta-D-glucan levels, and liver/renal function.

Main Results:

  • No cases of invasive fungal infection were detected during central venous catheter placement.
  • No infants showed elevated beta-D-glucan levels.
  • All infants survived until discharge.
  • No statistically significant differences in liver and renal function were observed before and after prophylaxis.

Conclusions:

  • Fosfluconazole prophylaxis is well-tolerated and effective in preventing IFIs in VLBW infants.
  • This study represents the first report on fosfluconazole use for antifungal prophylaxis in VLBW infants.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...